– SWITZERLAND – Covagen today announced that the company has secured CHF 42 million in a tranched Series B financing with an option to obtain an additional CHF 14 million that would increase the total amount of the financing round to CHF 56 million.…
– USA, MA – Intarcia Therapeutics, Inc. today announced the appointment of Nancy Thornberry to its Board of Directors.…
– UK,Oxford / USA,MA – Oxford Immunotec Global PLC (Nasdaq:OXFD) announced today that Herman (“Herm”) Rosenman has been appointed as a member of the Company’s Board of Directors and will serve as Chairman of the Board’s Audit Committee.…
– UZK, Cambridge – Crescendo Biologics Limited (Crescendo) today announces it has raised £17.5m ($28m) in a Series A financing led by Imperial Innovations and including new investor Astellas Venture Management (AVM).…
– USA, CA –OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, announced the appointment of Frederick W.…